Purified Anti-Mouse CD274/PD-L1 Antibody[10F.9G2]
![Purified Anti-Mouse CD274/PD-L1 Antibody[10F.9G2]](http://files.elabscience.cn/assets/images/loading.png)
Price:
Size:
100 μg
25 μg
- 应用性: FCM
- 亚型: Rat IgG2b, κ
- 宿主: Rat
Alternate Names | B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, B7 homolog 1, B7-H, B7-H1, Programmed cell death ligand 1 |
Clone No | |
Isotype | Rat IgG2b, κ |
Leadtime |
咨询
|
Verified Samples | Verified Samples in FCM: C57/BL6 Mouse splenocytes |
Dilution |
FCM 2 μg/mL(1×105-5×105 cells)
|
Background |
CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1 with PD-1 plays an important role in the inhibition of T cell responses. Other studies have shown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 is involved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, in an IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cell proliferation and cytokine production.
|
Immunogen | Recombinant Mouse CD274 protein |
Abbre | CD274/PD-L1 |
Swissprot | |
Host | Rat |
Reactivity | Mouse |
Clonality | Monoclonal |
Purification Method | >98%, Protein A/G purified |
Applications | |
Research Areas | Cancer Biomarkers;Costimulatory Molecules;Immunology |
Concentration | ≥ 1 mg/mL |
Conjugation | Unconjugated |
Storage Buffer | PBS, pH 7.2. Contains 0.05% proclin 300. |
Storage | Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. |
Expiration Date | 12个月 |
Shipping |
Ice bag |
C57/BL6 Mouse splenocytes were stained with 0.2 μg Purified Anti-Mouse CD274/PD-L1 Antibody[10F.9G2](Right) and 0.2 μg Rat IgG2b, κ Isotype Control(Left), followed by Alexa Fluor® 647-conjugated Goat Anti-Rat IgG Secondary Antibody.
-
Characterization of immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancers
IF: 3.800Journal: Scientific Reports (2024)Reactivity:MouseSample Type:4T1 cell-xenograft